Biotech group head juggles COVID-19 and drug pricing push

Between a deadly pandemic and ongoing efforts to overhaul the nation’s drug pricing system, there has been a lot on the plate of the Biotechnology Innovation Organization (BIO).Meanwhile, Michelle McMurry-Heath, CEO of the trade group — which…